GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Net Margin %

Philogen SpA (STU:78Q) Net Margin % : 83.05% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Philogen SpA's Net Income for the six months ended in Dec. 2024 was €60.81 Mil. Philogen SpA's Revenue for the six months ended in Dec. 2024 was €73.22 Mil. Therefore, Philogen SpA's net margin for the quarter that ended in Dec. 2024 was 83.05%.

The historical rank and industry rank for Philogen SpA's Net Margin % or its related term are showing as below:

STU:78Q' s Net Margin % Range Over the Past 10 Years
Min: -630.01   Med: -26.64   Max: 61.21
Current: 61.21


STU:78Q's Net Margin % is ranked better than
97.09% of 995 companies
in the Biotechnology industry
Industry Median: -119.91 vs STU:78Q: 61.21

Philogen SpA Net Margin % Historical Data

The historical data trend for Philogen SpA's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Net Margin % Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
-278.05 -630.01 -22.67 -26.64 61.21

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -130.68 35.48 -919.14 -1,991.78 83.05

Competitive Comparison of Philogen SpA's Net Margin %

For the Biotechnology subindustry, Philogen SpA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philogen SpA's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's Net Margin % distribution charts can be found below:

* The bar in red indicates where Philogen SpA's Net Margin % falls into.


;
;

Philogen SpA Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Philogen SpA's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=45.292/73.996
=61.21 %

Philogen SpA's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=60.808/73.217
=83.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philogen SpA  (STU:78Q) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Philogen SpA Net Margin % Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines